Search
for
Sort by
Research 181–210 of 1000+
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Treatment strategies for alopecia
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Congenital adrenal hyperplasia
- Testosterone therapy in men: Clinical and pharmacological perspectives
- The Hirsute Woman: Challenges in Evaluation and Management
- Antiandrogen Therapy for Skin and Hair Disease
- Novel inhibitors of 5α-reductase
- Androgenetic Alopecia: Clinical Aspects and Treatment
- Genetic basis of polycystic ovary syndrome
- Geranylated Coumarins From Thai Medicinal Plant Mammea siamensis With Testosterone 5α-Reductase Inhibitory Activity
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Managing polycystic ovary syndrome in primary care
- Menopausal Acne – Challenges And Solutions
- Oxidative stress in androgenetic alopecia.
- The Evaluation and Management of Hirsutism
- Hirsutism
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Types and Treatment of Hair Loss in Men and Women
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Antioxidation, Anti-Inflammation, and Regulation of SRD5A Gene Expression of Oryza sativa cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Considerations on Hair Research and Hair Growth
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA)